Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Clinical trial NCT06769126 · RECRUITING

Trial details

NCT number: NCT06769126
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Lung Small Cell Carcinoma, A Subtype Lung Small Cell Carcinoma, I Subtype Lung Small Cell Carcinoma, N Subtype Lung Small Cell Carcinoma, P Subtype

Start date: 2025-11-06
Primary completion: 2028-12-31
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.